C4 Therapeutics (CCCC) Asset Utilization Ratio (2020 - 2026)

C4 Therapeutics' Asset Utilization Ratio history runs 7 years deep, the most recent figure standing at 0.1 for Q1 2026.

• In Q1 2026, Asset Utilization Ratio fell 14.77% year-over-year to 0.1; the TTM figure through Mar 2026 stood at 0.1 (down 14.77% YoY), while the FY2025 annual figure was 0.1, up 3.5% from the prior year.
• Asset Utilization Ratio for Q1 2026 stood at 0.1, down from 0.12 in the prior quarter.
• The five-year high for Asset Utilization Ratio was 0.12 in Q1 2025, with the low at 0.04 in Q2 2023.
• The 5-year median for Asset Utilization Ratio is 0.09 (2022), against an average of 0.09.
• The sharpest annual moves came in 2023 and 2025: Asset Utilization Ratio plunged 58.14% in 2023, then surged 129.92% in 2025.
• C4 Therapeutics' Asset Utilization Ratio stood at 0.07 in 2022, then decreased by 16.05% to 0.06 in 2023, then surged by 67.61% to 0.1 in 2024, then increased by 17.37% to 0.12 in 2025, then decreased by 11.95% to 0.1 in 2026.
• Business Quant data shows CCCC's Asset Utilization Ratio at 0.1 in Q1 2026, 0.12 in Q4 2025, and 0.11 in Q3 2025.